• Go to navigation
  • Go to content
SEROQUEL (quetiapine)

Astrazeneca Worldwide

  • AstraZeneca Websites
az.com
  • Home

Main navigation

  • Home
  • SEROQUEL and SEROQUEL XR Prescribing information
  • SEROQUEL Mode of Action
  • SEROQUEL XR in schizophrenia
  • SEROQUEL in Schizophrenia
  • SEROQUEL in bipolar mania
  • Key publications
  • Assessment tools
  • SEROQUEL Information for patients
  • SEROQUEL XR Information for patients
  • Resources
  • About AstraZeneca
  • Sitemap

You are here

  • SEROQUEL and SEROQUEL XR Prescribing information
  • SEROQUEL and SEROQUEL XR prescribing information

Download SEROQUEL prescribing information (PDF)
Download SEROQUEL XR prescribing information (PDF)

Based on the Summary of Product Characteristics for Ireland. Please note that registration conditions differ internationally, so for Prescribing Information, please refer to the Summary of Product Characteristics for your home country.

 

 

SEROQUEL and SEROQUEL XR are trademarks of the AstraZeneca group.

© AstraZeneca 2009

Page tools

  • Print
  • Bookmark this page

Prescribing Information

Summary of Product Information

  • SEROQUEL
  • SEROQUEL XR

Please note

This is an AstraZeneca site for International Healthcare Professionals. Other visitors, see below:

US physicians & patients
UK physicians
UK patients
International patients
Investor & Journalists

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2010